Nerve Repair & Regeneration Market by Product (Biomaterials, Neurostimulation & Neuromodulation Devices), Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries), End-User - Global Forecast 2024-2030

Nerve Repair & Regeneration Market by Product (Biomaterials, Neurostimulation & Neuromodulation Devices), Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries), End-User - Global Forecast 2024-2030


The Nerve Repair & Regeneration Market size was estimated at USD 10.10 billion in 2023 and expected to reach USD 11.43 billion in 2024, at a CAGR 13.27% to reach USD 24.18 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nerve Repair & Regeneration Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nerve Repair & Regeneration Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nerve Repair & Regeneration Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acelity L.P. Inc., Alphatec Holdings, Inc., Axogen Corporation, B. Braun SE, Baxter International Inc., Boston Scientific Corporation, Checkpoint Surgical, Inc., Cigna Health and Life Insurance Company, Convatec Group plc, Integra Life Sciences Corporation, KLS Martin Group, Medtronic plc, Neuraptive Therapeutics, Inc., NuVasive, Inc., Orthofix International NV, Siemens Healthcare GmbH, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Nerve Repair & Regeneration Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Biomaterials
Nerve Conduits
Nerve Connectors
Nerve Protectors
Nerve Wraps

Neurostimulation & Neuromodulation Devices
External Neurostimulation Devices
Internal Neurostimulation Devices
Application

Direct Nerve Repair/Neurorrhaphy
Epineural Repair
Group Fascicular Repair
Perineural Repair

Nerve Grafting
Allografts
Autografts
Xenografts

Neurostimulation & Neuromodulation Surgeries

Stem Cell Therapy
End-User

Ambulatory Surgery Centers

Hospitals & Clinics
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Nerve Repair & Regeneration Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nerve Repair & Regeneration Market?
3. What are the technology trends and regulatory frameworks in the Nerve Repair & Regeneration Market?
4. What is the market share of the leading vendors in the Nerve Repair & Regeneration Market?
5. Which modes and strategic moves are suitable for entering the Nerve Repair & Regeneration Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Nerve Repair & Regeneration Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Enlarging cases of neurological disorders across the globe
5.1.1.2. Increasing number of peripheral nerve injuries among geriatric population
5.1.1.3. Surging trend of sports and recreational activities
5.1.2. Restraints
5.1.2.1. Limited number of neuro surgeons and neuro physicians worldwide
5.1.3. Opportunities
5.1.3.1. Emerging innovation in peripheral nerve regeneration techniques
5.1.3.2. Ongoing advancements in tissue engineering and regenerative medicine
5.1.4. Challenges
5.1.4.1. Concern regarding functional recovery issues after nerve repair surgery
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Nerve Repair & Regeneration Market, by Product
6.1. Introduction
6.2. Biomaterials
6.3.1. Nerve Conduits
6.3.2. Nerve Connectors
6.3.3. Nerve Protectors
6.3.4. Nerve Wraps
6.3. Neurostimulation & Neuromodulation Devices
6.4.1. External Neurostimulation Devices
6.4.2. Internal Neurostimulation Devices
7. Nerve Repair & Regeneration Market, by Application
7.1. Introduction
7.2. Direct Nerve Repair/Neurorrhaphy
7.3.1. Epineural Repair
7.3.2. Group Fascicular Repair
7.3.3. Perineural Repair
7.3. Nerve Grafting
7.4.1. Allografts
7.4.2. Autografts
7.4.3. Xenografts
7.4. Neurostimulation & Neuromodulation Surgeries
7.5. Stem Cell Therapy
8. Nerve Repair & Regeneration Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals & Clinics
9. Americas Nerve Repair & Regeneration Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Nerve Repair & Regeneration Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Nerve Repair & Regeneration Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Axonics Acquired Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Minnesota Partnership for Biotechnology and Medical Genomics awarded three collaborative research grants
12.3.2.2. Toyobo launched major marketing initiative for Nerbridge(TM) in the U.S., setting sights on the global nerve conduit market
12.3.3. New Product Launch & Enhancement
12.3.3.1. LivaNova introduced SenTiva DUO implantable pulse generator for epilepsy
12.3.3.2. Checkpoint Surgical launched CHECKPOINT GEMINI Bipolar Nerve Stimulator for precise stimulation
12.3.3.3. Checkpoint Surgical introduced new nerve cutting kit
12.3.3.4. Axogen, Inc. Announced Positive Topline Results from Phase 3 RECON(SM) Study for Avance Nerve Graft
12.3.4. Investment & Funding
12.3.4.1. BioCircuit Technologies, Inc. Closes a USD 9 million Series Seed Round
12.3.4.2. MicroTransponder received macro funding round with USD 73M for stroke rehab neurostimulator
12.3.5. Award, Recognition, & Expansion
12.3.5.1. FDA cleared Neuspera Medical peripheral nerve stim
12.3.5.2. FDA Approves Abbott's Spinal Cord Stimulation For People Living With Painful Diabetic Peripheral Neuropathy
12.3.5.3. BioCircuit Technologies Announced FDA 510(k) Clearance of Nerve Tape Device
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Acelity L.P. Inc.
13.1.3. Alphatec Holdings, Inc.
13.1.4. Axogen Corporation
13.1.5. B. Braun SE
13.1.6. Baxter International Inc.
13.1.7. Boston Scientific Corporation
13.1.8. Checkpoint Surgical, Inc.
13.1.9. Cigna Health and Life Insurance Company
13.1.10. Convatec Group plc
13.1.11. Integra Life Sciences Corporation
13.1.12. KLS Martin Group
13.1.13. Medtronic plc
13.1.14. Neuraptive Therapeutics, Inc.
13.1.15. NuVasive, Inc.
13.1.16. Orthofix International NV
13.1.17. Siemens Healthcare GmbH
13.1.18. Smith & Nephew plc
13.1.19. Stryker Corporation
13.1.20. Zimmer Biomet Holdings, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. NERVE REPAIR & REGENERATION MARKET RESEARCH PROCESS
FIGURE 2. NERVE REPAIR & REGENERATION MARKET SIZE, 2023 VS 2030
FIGURE 3. NERVE REPAIR & REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NERVE REPAIR & REGENERATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NERVE REPAIR & REGENERATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NERVE REPAIR & REGENERATION MARKET DYNAMICS
FIGURE 7. NERVE REPAIR & REGENERATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. NERVE REPAIR & REGENERATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NERVE REPAIR & REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. NERVE REPAIR & REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NERVE REPAIR & REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. NERVE REPAIR & REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NERVE REPAIR & REGENERATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES NERVE REPAIR & REGENERATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. NERVE REPAIR & REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. NERVE REPAIR & REGENERATION MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings